<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6921558/results/search/disease/results.xml">
  <result pre="22] and opioids [ 23] has also been described in" exact="cerebral palsy." post="Among neuropsychiatric disorders, neuromuscular diseases are considered at the"/>
  <result pre="are considered at high risk of specific anesthesiologic complications as" exact="malignant hyperthermia" post="or rhabdomyolysis, in particular after inhaled anesthetics’ administration ["/>
  <result pre="non-sevoflurane-based anesthesia (16.2 vs. 8.6%; p = 0.012) and affected by" exact="neuromuscular disease" post="(22.8 vs. 8.6%; p &amp;lt; 0.001) were significantly more frequently ventilated."/>
  <result pre="50 min and for respiratory complications ASA score, presence of a" exact="neuromuscular disease," post="anesthesia length superior to 50 min and season autumn-winter; they"/>
  <result pre="R Berkenbosch JW Dexmedetomidine for procedural sedation in children with" exact="autism" post="and other behavior disorders Paediatr Neurol 2009 41 88"/>
  <result pre="Kern C Minimum alveolar concentration for halothane in children with" exact="cerebral palsy" post="and severe mental retardation Anaesth 1997 52 1056 1060"/>
  <result pre="MC Akins RE Surgery and anesthesia for children who have" exact="cerebral palsy" post="Anesth Clin North Am 2005 23 733 743 10.1016/j.atc.2005.08.001"/>
  <result pre="Lerman J Perioperative management of the paediatric patient with coexisting" exact="neuromuscular disease" post="Br J Anaesth 2011 107 Suppl 1 i79 i89"/>
  <result pre="JA Finder JD Perioperative respiratory management of pediatric patients with" exact="neuromuscular disease" post="Paediatr Anaesth 2013 23 9 770 776 10.1111/pan.12214 23763308"/>
  <result pre="T Erhan OL Anaesthesia management in a child with metabolic" exact="myopathy" post="Eur Rev Med Pharmacol Sci 2014 18 22 3347"/>
 </snippets>
</snippetsTree>
